S&N Evaluating Oxinium Knee Loosening; Revised Design, Technique Possible
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew's voluntary U.S. market withdrawal of cementless Oxinium Genesis II and Oxinium Profix total knee systems does not affect cemented versions of the devices and will have a "minimal" financial impact on the company, the firm contends
You may also be interested in...
Smith & Nephew knee revisions
Macrotextured knee implant revision surgeries total 295 as of April 30, the firm reports. S&N's voluntary August 2003 U.S. market withdrawal of cementless Oxinium Genesis II and Oxinium Profix total knee systems followed reports of implant loosening (1"The Gray Sheet" Sept. 22, 2003, p. 15). The firm "continue[s] to believe the withdrawal remains manageable," S&N says. Fiscal first quarter (ended April 3) knee sales growth of 24% and hip sales up 18% aided a 17% advance in orthopedic revenues. Sales advanced 9% to about $538 mil. for the quarter...
Smith & Nephew knee revisions
Macrotextured knee implant revision surgeries total 295 as of April 30, the firm reports. S&N's voluntary August 2003 U.S. market withdrawal of cementless Oxinium Genesis II and Oxinium Profix total knee systems followed reports of implant loosening (1"The Gray Sheet" Sept. 22, 2003, p. 15). The firm "continue[s] to believe the withdrawal remains manageable," S&N says. Fiscal first quarter (ended April 3) knee sales growth of 24% and hip sales up 18% aided a 17% advance in orthopedic revenues. Sales advanced 9% to about $538 mil. for the quarter...
Knee Implant Wear Debris, Changing Demographics Weighed By NIH Panel
Optimal implant designs for total knee replacement (TKR) surgeries tailored to specific patient populations will be considered by panelists at an NIH Consensus Development Conference in Bethesda, Md. Dec. 8-10